FDA Orange Book Includes New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Solution for Bacterial Vaginosis and Trichomoniasis
Evofem's Patent Portfolio: Evofem Biosciences has secured a new U.S. patent for SOLOSEC, extending its market exclusivity until December 2041 and enhancing its intellectual property portfolio.
SOLOSEC Overview: SOLOSEC is the first FDA-approved single-dose oral treatment for bacterial vaginosis and trichomoniasis, designed to simplify treatment adherence with just one dose.
Clinical Trial Initiatives: A Phase 4 clinical trial is underway to compare the effectiveness of SOLOSEC against metronidazole, hypothesizing that SOLOSEC will result in lower rates of reinfection.
Upcoming Merger Plans: Evofem is preparing for a merger with Aditxt, Inc., which requires stockholder approval and sufficient capital from Aditxt to proceed with the transaction.
Trade with 70% Backtested Accuracy
Analyst Views on ADTX
About ADTX
About the author
Aditxt Inc. (ADTX) Completes Reverse Split, Shares Surge Over 20%
- Stock Price Surge: Aditxt Inc. saw its stock price rise over 20% to $1.44 in premarket trading on Wednesday, indicating strong market confidence in its immune modulation technologies and future growth prospects.
- Reverse Stock Split: The company executed a 1-for-113 reverse stock split on January 11, 2026, aimed at maintaining compliance with Nasdaq's minimum bid price requirements, thereby enhancing its market appeal and compliance status.
- Special Shareholder Meeting: Aditxt has scheduled a virtual special shareholder meeting for January 30, 2026, where shareholders will vote on significant capital and governance proposals, including the authorization of convertible preferred stock, which could profoundly impact the company's future financing capabilities.
- Employee Stock Purchase Plan: The meeting will propose the adoption of a 2025 Employee Stock Purchase Plan reserving 200,000 shares, designed to incentivize employees and strengthen the internal shareholder structure, thereby enhancing employee engagement and productivity.
GameStop Corp (GME) CEO Ryan Cohen Buys 500,000 Shares, Stock Rises 2.6%
- CEO Stock Purchase: GameStop CEO Ryan Cohen disclosed the purchase of 500,000 shares at an average price of approximately $21.12 per share in an SEC filing, which not only boosts market confidence but may also enhance investor expectations regarding the company's future growth.
- Stock Price Surge: Following this announcement, GameStop's stock rose 2.6% to $21.65 in pre-market trading, indicating a positive market reaction to the company's strategic direction, potentially attracting more investor interest.
- Market Movements: Pineapple Financial saw a dramatic increase of 175.2% to $2.67 in pre-market trading, reflecting market recognition of its first-quarter gross billings of $4.1 million and revenue of $0.7 million, showcasing its future growth potential.
- Other Stock Performances: Anteris Technologies announced plans for a $200 million public offering, resulting in a 26.4% increase in its stock price to $7.27, indicating a positive market response to its capital expansion plans, which may provide funding support for future growth.
Dow Rises by 150 Points as Jabil Reports Positive Earnings
U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow Jones rising approximately 150 points, while the NASDAQ and S&P 500 also experienced slight increases. Energy shares led the rise, up by 1%, while information technology stocks fell by 0.1%.
Earnings Reports: Jabil Inc reported better-than-expected earnings for its first quarter, with adjusted earnings of $2.85 per share, surpassing estimates. In contrast, Children's Place Inc faced a significant drop in shares following disappointing third-quarter results.
Notable Stock Movements: Vyne Therapeutics shares surged 66% after announcing a merger agreement, while Agape ATP Corp and Aditxt Inc also saw substantial increases in their stock prices. Conversely, Vistagen Therapeutics experienced a dramatic 79% drop after failing to meet study endpoints.
Global Market Trends: European shares were mixed, with the STOXX 600 gaining slightly, while Asian markets mostly closed higher, led by Japan and Hong Kong. Additionally, mortgage applications in the U.S. fell by 3.8% in the latest week.
Stock Market Update: S&P 500 and Dow Futures Rise Amid Jobs Data Impact—Focus on Lennar, Micron Technology, and Children's Place
U.S. Stock Market Update: U.S. stock futures rose on Wednesday following a mixed close on Tuesday, with major indices showing gains. The delayed jobs report indicated a rise in unemployment to 4.6%, leading to debates among economists about its implications for the economy.
Sector Performance: On Tuesday, the Information Technology, Consumer Discretionary, and Communication Services sectors saw gains, while other sectors like Energy and Health Care experienced declines. Notable stock movements included Lennar Corp. dropping 3.78% and Micron Technology rising 3.36%.
Analyst Insights: Analyst Jeremy Siegel predicts a supportive economic shift due to a dovish Federal Reserve, suggesting a potential end to quantitative tightening. He anticipates a market rotation beyond tech giants and a stable economic environment that avoids recession.
Global Market Trends: Asian markets closed mixed, with some indices rising while others fell. Crude oil and gold prices increased, and Bitcoin saw a slight rise. European markets opened higher, indicating a positive trend in global equity markets.
Aditxt Shares Surge Approximately 63%; Check Out 20 Stocks Making Moves in Premarket Trading
Aditxt Inc Stock Surge: Aditxt Inc's shares rose 63.4% to $2.32 in pre-market trading after filing a definitive proxy statement for a special stockholder meeting on January 30, 2026, regarding compliance with Nasdaq rules on share issuances.
Other Notable Gainers: Several stocks saw significant pre-market gains, including Agape ATP Corp (+66%), Direct Digital Holdings Inc (+35.3%), and DBV Technologies SA (+30.3%) following positive trial results.
Major Losers: Children's Place Inc experienced a sharp decline of 32.1% to $4.99 after disappointing third-quarter results, while other notable losers included AlphaVest Acquisition Corp (-19.8%) and Kyverna Therapeutics Inc (-19.2%).
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies recovering from previous declines while others faced significant drops in share prices.
What Caused Aditxt (ADTX) Stock to Jump 52% in After-Hours Trading?
Stock Surge: Aditxt Inc. (NASDAQ: ADTX) shares rose 52.11% to $2.16 in after-hours trading following the announcement of a special stockholder meeting scheduled for January 30, 2026.
Shareholder Proposals: The proxy statement includes several proposals for shareholder approval, including compliance with Nasdaq rules for stock issuances, an Employee Stock Purchase Plan, and an amendment to the Omnibus Equity Incentive Plan.
Reverse Stock Split and Name Change: The board seeks approval for a potential reverse stock split and a non-binding advisory vote on changing the company name to "bitXbio, Inc."
Trading Performance: Despite the recent surge, ADTX has experienced a 99.97% decline year-to-date, with a current market capitalization of approximately $794,410.
Aditxt Inc. (ADTX) Completes Reverse Split, Shares Surge Over 20%
- Stock Price Surge: Aditxt Inc. saw its stock price rise over 20% to $1.44 in premarket trading on Wednesday, indicating strong market confidence in its immune modulation technologies and future growth prospects.
- Reverse Stock Split: The company executed a 1-for-113 reverse stock split on January 11, 2026, aimed at maintaining compliance with Nasdaq's minimum bid price requirements, thereby enhancing its market appeal and compliance status.
- Special Shareholder Meeting: Aditxt has scheduled a virtual special shareholder meeting for January 30, 2026, where shareholders will vote on significant capital and governance proposals, including the authorization of convertible preferred stock, which could profoundly impact the company's future financing capabilities.
- Employee Stock Purchase Plan: The meeting will propose the adoption of a 2025 Employee Stock Purchase Plan reserving 200,000 shares, designed to incentivize employees and strengthen the internal shareholder structure, thereby enhancing employee engagement and productivity.
GameStop Corp (GME) CEO Ryan Cohen Buys 500,000 Shares, Stock Rises 2.6%
- CEO Stock Purchase: GameStop CEO Ryan Cohen disclosed the purchase of 500,000 shares at an average price of approximately $21.12 per share in an SEC filing, which not only boosts market confidence but may also enhance investor expectations regarding the company's future growth.
- Stock Price Surge: Following this announcement, GameStop's stock rose 2.6% to $21.65 in pre-market trading, indicating a positive market reaction to the company's strategic direction, potentially attracting more investor interest.
- Market Movements: Pineapple Financial saw a dramatic increase of 175.2% to $2.67 in pre-market trading, reflecting market recognition of its first-quarter gross billings of $4.1 million and revenue of $0.7 million, showcasing its future growth potential.
- Other Stock Performances: Anteris Technologies announced plans for a $200 million public offering, resulting in a 26.4% increase in its stock price to $7.27, indicating a positive market response to its capital expansion plans, which may provide funding support for future growth.
Dow Rises by 150 Points as Jabil Reports Positive Earnings
U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow Jones rising approximately 150 points, while the NASDAQ and S&P 500 also experienced slight increases. Energy shares led the rise, up by 1%, while information technology stocks fell by 0.1%.
Earnings Reports: Jabil Inc reported better-than-expected earnings for its first quarter, with adjusted earnings of $2.85 per share, surpassing estimates. In contrast, Children's Place Inc faced a significant drop in shares following disappointing third-quarter results.
Notable Stock Movements: Vyne Therapeutics shares surged 66% after announcing a merger agreement, while Agape ATP Corp and Aditxt Inc also saw substantial increases in their stock prices. Conversely, Vistagen Therapeutics experienced a dramatic 79% drop after failing to meet study endpoints.
Global Market Trends: European shares were mixed, with the STOXX 600 gaining slightly, while Asian markets mostly closed higher, led by Japan and Hong Kong. Additionally, mortgage applications in the U.S. fell by 3.8% in the latest week.
Stock Market Update: S&P 500 and Dow Futures Rise Amid Jobs Data Impact—Focus on Lennar, Micron Technology, and Children's Place
U.S. Stock Market Update: U.S. stock futures rose on Wednesday following a mixed close on Tuesday, with major indices showing gains. The delayed jobs report indicated a rise in unemployment to 4.6%, leading to debates among economists about its implications for the economy.
Sector Performance: On Tuesday, the Information Technology, Consumer Discretionary, and Communication Services sectors saw gains, while other sectors like Energy and Health Care experienced declines. Notable stock movements included Lennar Corp. dropping 3.78% and Micron Technology rising 3.36%.
Analyst Insights: Analyst Jeremy Siegel predicts a supportive economic shift due to a dovish Federal Reserve, suggesting a potential end to quantitative tightening. He anticipates a market rotation beyond tech giants and a stable economic environment that avoids recession.
Global Market Trends: Asian markets closed mixed, with some indices rising while others fell. Crude oil and gold prices increased, and Bitcoin saw a slight rise. European markets opened higher, indicating a positive trend in global equity markets.
Aditxt Shares Surge Approximately 63%; Check Out 20 Stocks Making Moves in Premarket Trading
Aditxt Inc Stock Surge: Aditxt Inc's shares rose 63.4% to $2.32 in pre-market trading after filing a definitive proxy statement for a special stockholder meeting on January 30, 2026, regarding compliance with Nasdaq rules on share issuances.
Other Notable Gainers: Several stocks saw significant pre-market gains, including Agape ATP Corp (+66%), Direct Digital Holdings Inc (+35.3%), and DBV Technologies SA (+30.3%) following positive trial results.
Major Losers: Children's Place Inc experienced a sharp decline of 32.1% to $4.99 after disappointing third-quarter results, while other notable losers included AlphaVest Acquisition Corp (-19.8%) and Kyverna Therapeutics Inc (-19.2%).
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies recovering from previous declines while others faced significant drops in share prices.
What Caused Aditxt (ADTX) Stock to Jump 52% in After-Hours Trading?
Stock Surge: Aditxt Inc. (NASDAQ: ADTX) shares rose 52.11% to $2.16 in after-hours trading following the announcement of a special stockholder meeting scheduled for January 30, 2026.
Shareholder Proposals: The proxy statement includes several proposals for shareholder approval, including compliance with Nasdaq rules for stock issuances, an Employee Stock Purchase Plan, and an amendment to the Omnibus Equity Incentive Plan.
Reverse Stock Split and Name Change: The board seeks approval for a potential reverse stock split and a non-binding advisory vote on changing the company name to "bitXbio, Inc."
Trading Performance: Despite the recent surge, ADTX has experienced a 99.97% decline year-to-date, with a current market capitalization of approximately $794,410.
